- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.03. | Linearis Opens New Lab in Quebec | ||
| 26.03. | Singota Solutions Opens New Facility in Balerna, Switzerland | ||
| 26.03. | Sanofi's Chlamydia Vaccine Candidate Granted Fast Track Designation by FDA | ||
| 26.03. | Theratechnologies Receives FDA Approval for EGRIFTA WR | ||
| 26.03. | GSK's Blujepa Approved by FDA for Treatment of uUTIs | ||
| 25.03. | Cytiva Expands Xcellerex X-Platform Portfolio | ||
| 25.03. | AstraZeneca to Invest $2.5B in New Global R&D Center in Beijing | ||
| 25.03. | Merck & Co. Enters License Agreement with Jiangsu Hengrui Pharmaceuticals | ||
| 25.03. | BioDuro Opens New Lab in Shanghai | ||
| 25.03. | c-Lecta Launches GMP-Grade Version of Denarase High Salt | ||
| 25.03. | Carbogen Amcis Granted GMP Certificate for Saint-Beauzire Facility | ||
| 24.03. | Likarda Receives Gates Foundation Grant to Support its Core-Shell Spherification System | ||
| 24.03. | OFD Life Sciences Announces Leadership Changes | ||
| 24.03. | J&J Ups U.S. Investment to More Than $55B | ||
| 24.03. | Novo Nordisk Secures Triple Agonist UBT251 in $2B Deal | ||
| 24.03. | Everest Medicine's IND Application for EVM14 Cleared by FDA | ||
| 24.03. | Pathios Therapeutics Names Sumeet Ambarkhane as Chief Medical Officer | ||
| 21.03. | Roche & Oxford BioTherapeutics Partner on Novel Cancer Therapies | ||
| 21.03. | Sanofi to Acquire DR-0201 from Dren Bio | ||
| 21.03. | Syneron Bio, AstraZeneca Partner to Develop Macrocyclic Peptides | ||
| 21.03. | Wheeler Bio Closes $35M Series A-1 Financing Round | ||
| 20.03. | Life Sciences Lead the Way in Pittsburgh's Tech Ecosystem | ||
| 20.03. | Akari Therapeutics Appoints Abizer Gaslightwala President and CEO | ||
| 20.03. | Grifols, Inpeco Partner to Modernize Lab Operations | ||
| 20.03. | Coronado Research Appoints Gary Lyons as EVP of Medical Affairs |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
